StockWatch
·
Pharmaceutical Preparations
Loan & DebtAug 12, 2026, 05:02 PM

OS Therapies Secures $10M in Private Placement of Convertible Notes

AI Summary

OS Therapies Inc. entered into a securities purchase agreement for a private placement of up to $10,000,000 in senior secured convertible promissory notes. The company completed the initial closing of the First Tranche, raising $5,000,000, which included the conversion of a $2,200,000 bridge note. The proceeds are intended for clinical development, regulatory activities, and general corporate purposes.

Key Highlights

  • Secured up to $10,000,000 in a private placement of senior secured convertible promissory notes.
  • Initial closing of the First Tranche completed for $5,000,000.
  • Issued Notes with an aggregate principal amount of $5,405,405.42, including a 7.5% original issue discount.
  • Issued 600,000 shares of common stock, Pre-Funded Warrants for 900,000 shares, and Warrants for 1,500,000 shares.
  • A $2,200,000 bridge note converted into a Note, Pre-Funded Warrant (660,000 shares), and Warrant (660,000 shares).
  • Proceeds will fund clinical development, regulatory activities, working capital, and general corporate purposes.
  • Company agreed to file a registration statement within 30 days for resale of securities.